Biosimilars Market Strategy


Effective management of a current good manufacturing practice (GMP) facility requires a strict eye on all those factors. This also includes Bioanalytical methods, Formulation, Bioassay for comparability and potency testing, GMP protein analysis, LC/MS analysis for discovery, preclinical, and clinical programs. Analysis of Biosimilars and Biologics forms to be one of the most important aspects towards the Biologics and Biosimilar development process. On average, facilities outsource 32% of their analytical testing/bioassays (up from 28%) meaning that close to one-third of analytical testing is estimated to be outsourced by the industry. The market for Biosimilars follow-on-Biologics is expected to grow at an exponential rate for next decade with the expiry of most patented drugs by 2020.The market in the APAC region for Biosimilars reached $605 million in 2010 and $683 million in 2011. The market is expected to reach $1.1 billion by 2016, a CAGR of 10.3%. The market in the United States for Biosimilars reached $507 million in 2010 and $1.1 billion in 2011. The market is expected to reach $1.3 billion by 2016, a CAGR of 4.1%.


    Related Conference of Biosimilars Market Strategy

    May 12-12, 2021

    27th Cognitive Neuroscience Congress

    London, UK
    May 17-17, 2021

    Annual Meet on Pharmacovigilance & Drug Safety

    Tokyo, Japan
    May 17-18, 2021

    8th European Biopharma Congress

    Prague, Czech Republic
    June 07-08, 2021

    2nd European Conference on Pharmacovigilance and Drug Safety

    Prague, Czech Republic
    June 21-22, 2021

    1 st Global Summit on Generic Drugs and Quality Control

    Prague, Czech Republic
    July 06-07, 2021

    14th Global Pharmacovigilance And Clinical Trials Summit

    Albufeira, Portugal
    July 10-11, 2021

    2 nd Pharma Expo China

    Tokyo, Japan
    July 13-14, 2021

    24th Asia Pacific Pharma Congress

    Melbourne,
    July 26-27, 2021

    36th World Pharmacology and Therapeutics Forum

    Paris, France
    July 30-30, 2021

    12th World Congress on Bioavailability and Bioequivalence

    Prague, Czech Republic
    August 16-17, 2021

    Global summit on Cosmetic & Reconstructive Surgery

    Tokyo, Japan
    August 16-17, 2021

    34rd World Congress on Pharmacology

    London, UK
    August 23-24, 2021

    7th World Congress on Medicinal Plants and Marine Drugs

    Prague, Czech Republic
    August 30-31, 2021

    20th Medicinal & PharmaceuticalSciences Congress

    London, UK
    September 13-14, 2021

    3rd World Congress on Drug Discovery and Drug Design

    Tokyo, Japan
    September 17-18, 2021

    9th International Conference on Clinical Trials

    Montreal, Canada
    September 20-21, 2021

    Asia Pacific Pharmaceutics & Drug Delivery Congress

    Tokyo, Japan
    September 27-28, 2021

    2 nd World Pharma Expo

    Tokyo, Japan
    October 05-06, 2021

    International Congress on Drug Delivery

    Auckland, Newzealand
    October 21-22, 2021

    2nd Annual Congress on Antibiotics and Bacterial Infections

    Geneva, Switzerland
    October 29-30, 2021

    14th World Drug Delivery Summit

    Vancouver, Canada
    October 29-30, 2021

    12th Annual Biomarkers and Clinical Research Congress

    Vancouver, Canada
    November 16-17, 2021

    World Congress on Biologics and Biosimilars

    Osaka, Japan
    November 26-27, 2021

    World Biosimilars & Biologics Congress

    Vancouver, Canada
    December 02-03, 2021

    17th Annual Congress on Pharmacology and Toxicology

    Tokyo, Japan
    December 02-03, 2021

    International Conference on Bio Pharmaceutics

    Auckland, Newzealand
    December 07-08, 2021

    2nd International Conference on Biotechnology and Healthcare

    Auckland, Newzealand
    December 15-16, 2021

    12th World Congress on Bioavailability and Bioequivalence

    Bali, Indonesia

    Biosimilars Market Strategy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in